Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-21

FDA Approved: ROPIVACAINE HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's original application for generic ropivacaine hydrochloride, a local anesthetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropivacaine hydrochloride (ropivacaine hydrochloride)

Snippet

ORIG AP for ROPIVACAINE HYDROCHLORIDE (ROPIVACAINE HYDROCHLORIDE)